In addition to HbA1c measurement, SURPASS3 included a continuous glucose monitoring substudy to evaluate 24hour glucose profiles, as well as a magnetic resonance imaging (MRI) substudy to examine the effect of treatment on liver fat content and other measures, such as visceral fat
Could be circulation issues
SeekPeptides has compiled this evidence-based resource to help researchers navigate the complex landscape of metabolic optimization compounds
The peptide was named for a change in a frequency band
To learn more about how we can support your weight loss journey, contact us at 646.627.8000, fill out this form for a complimentary discovery call, or email [email protected] References:
The results indicated that LMP mutation carriers had a 3.03% lower overall weight loss compared to non-carriers, with no significant difference in short-term outcomes ( 6 months) but a significant reduction in long-term outcomes